Literature DB >> 23063142

Characterization of mid-term atrial geometrical and electrical remodeling following device closure of atrial septal defects in adults.

Fang Fang1, Xiu-Xia Luo, Qing-Shan Lin, Joey S W Kwong, Yan-Chao Zhang, Xin Jiang, Cheuk-Man Yu, Yat-Yin Lam.   

Abstract

PURPOSE: Late-onset atrial arrhythmia after successful closure of atrial septal defect (ASD) is not uncommon. Right atrial (RA) enlargement and increased electrocardiographic P-wave dispersion (Pd) independently predict the development of atrial arrhythmia. Data on the degree of right atrial (RA) geometrical and electrical remodeling following device closure of ASD are limited.
METHODS: Echocardiography and electrocardiography (ECG) were performed in 58 consecutive patients (47 ± 17 years) before and at 3 months after ASD closure. Persistent RA enlargement was defined as RA volume index (RAVI) ≥ 21 ml/m(2) at 3 months. Pd was calculated as the difference between maximal and minimal P-wave durations in 12-lead ECG.
RESULTS: RA size reduced (RAVI: 50 ± 28 vs. 26 ± 16 ml/m(2), p<0.001) and Pd on ECG decreased (53 ± 17 vs. 49 ± 20 ms, p<0.05) significantly at 3 months when compared to baseline. However, persistent RA enlargement remained evident in 31 patients (53%). As a group, they were older with higher pulmonary arterial systolic pressure, larger Qp/Qs, longer maximal P-wave duration and Pd than those with normalized RA. Pd reduction only occurred in patients with normalized RA size. The 3-month Pd (hazard ratio: 1.033, p<0.001) predicted the presence of incomplete RA geometrical remodeling. ROC curve revealed that Pd ≥ 45 ms at 3 months was 77% sensitive and 86% specific in revealing residual RA enlargement.
CONCLUSION: Both atrial geometrical and electrical reverse remodeling were evident at 3 months following ASD closure. However, only half of the included patients had normalization of RA size which could be revealed by a simple ECG surrogate of intra-atrial conduction disturbance.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  ACEI; ARB; ASD; Atrial septal defect; Atrial size; CI; Device closure; ECG; Geometrical and electrical remodeling; HR; LV; P-wave dispersion; Pd; Qp/Qs ratio; RA; RAVI; RV; angiotensin II receptor blockers; angiotensin converting enzyme inhibitor; atrial septal defect; confidence interval; electrocardiography; hazard ratio; left ventricular; ratio of pulmonary-to-systemic blood flow; right atrial; right atrial volume index; right ventricular

Mesh:

Year:  2012        PMID: 23063142     DOI: 10.1016/j.ijcard.2012.09.119

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

1.  Early and six-month assessment of bi-ventricular functions following surgical closure of atrial septal defect.

Authors:  Rajesh Vijayvergiya; Jiten Singh; Sandeep S Rana; Ranjan Shetty; Bhagwant R Mittal
Journal:  Indian Heart J       Date:  2014-11-10

2.  Longitudinal evaluation of P-wave dispersion and P-wave maximum in children after transcatheter device closure of secundum atrial septal defect.

Authors:  Robert Teodoro Grignani; Kim Martin Tolentino; Dimple Dayaram Rajgor; Swee Chye Quek
Journal:  Pediatr Cardiol       Date:  2015-01-28       Impact factor: 1.655

3.  Comparison of primary repair and patch plasty procedure on the P wave in adult atrial septal defect closure.

Authors:  Alper Ucak; Veysel Temizkan; Murat Ugur; Ahmet Erturk Yedekci; Omer Uz; Arif Selcuk; Ahmet Turan Yilmaz
Journal:  Cardiovasc J Afr       Date:  2016-05-04       Impact factor: 1.167

4.  Pathophysiology and Management of Arrhythmias Associated with Atrial Septal Defect and Patent Foramen Ovale.

Authors:  Henry Chubb; John Whitaker; Steven E Williams; Catherine E Head; Natali Ay Chung; Matthew J Wright; Mark O'Neill
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-11-29

5.  Immediate and short term effects of percutaneous atrial septal defect device closure on cardiac electrical remodeling in children.

Authors:  Alaa Mahmoud Roushdy; Hebatalla Attia; Heba Nossir
Journal:  Egypt Heart J       Date:  2018-03-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.